Lv2
150 积分 2024-05-28 加入
Discovery of Daraxonrasib (RMC-6236), a Potent and Orally Bioavailable RAS(ON) Multi-selective, Noncovalent Tri-complex Inhibitor for the Treatment of Patients with Multiple RAS-Addicted Cancers
4天前
已完结
Experimental JAK inhibitors: the current, present, and future in graft-versus-host disease management?
1个月前
已完结
A Review of Hair Anatomy and Animal Models for Alopecia
1个月前
已关闭
Prevalence of lichen planopilaris and frontal fibrosing alopecia in the United States: an All of Us database analysis
1个月前
已完结
Frontal fibrosing alopecia part II: Etiopathogenesis and management
1个月前
已完结
MTAP deficiency confers resistance to cytosolic nucleic acid sensing and STING agonists
2个月前
已完结
Efficacy and Safety of The Albumin‐Bound Paclitaxel Combined with Anti‐PD‐1 Antibody in Pancreatic Ductal Adenocarcinoma
3个月前
已完结
311eP Exploration of the mechanism of anlotinib in reversing PD-1 immunotherapy resistance: Insights from single-cell sequencing
3个月前
已完结
MYC in cancer: from undruggable target to clinical trials
4个月前
已完结
皖公网安备34019202002308
